E-LIB Suche - Ergebnisse für: Yu-Chih, Lin

1

OS-123 Progression and risk factors after treatment with te..:

Wu, Wan-Jung ; Liu, Wen-Jie ; Lin, Chih-Lin...
Journal of Hepatology. 80 (2024) - p. S75 , 2024

Link: https://doi.org/10.1016/..

2

THU-365 Real-world effectiveness and safety of 8-week gleca..:

Huang, Chung-Feng ; Chang, Te-Sheng ; Kuo, Hsing-Tao...
Journal of Hepatology. 80 (2024) - p. S832-S833 , 2024

Link: https://doi.org/10.1016/..

3

Real-World Efficacy and Safety of Universal 8-Week Glecapre..:

Yang, Chun-Chi ; Huang, Chung-Feng ; Chang, Te-Sheng...
Infectious Diseases and Therapy. 13 (2024) 6 - p. 1199-1213 , 2024

Link: https://doi.org/10.1007/..

4

Dynamic change of metabolic dysfunction-associated steatoti..:

Liu, Chen-Hua ; Chang, Yu-Ping ; Fang, Yu-Jen...
Journal of Gastroenterology. 59 (2024) 7 - p. 609-620 , 2024

Link: https://doi.org/10.1007/..

5

Effectiveness and safety of 8-week glecaprevir/pibrentasvir..:

Chang, Te-Sheng ; Huang, Chung-Feng ; Kuo, Hsing-Tao...
Hepatology International. 17 (2023) 3 - p. 550-561 , 2023

Link: https://doi.org/10.1007/..

6

Taiwan Association for the Study of the Liver-Taiwan Societ..:

Cheng, Pin-Nan ; Chen, Wen-Jone ; Hou, Charles Jia-Yin...
Clinical and Molecular Hepatology. 30 (2023) 1 - p. 16-36 , 2023

Link: https://doi.org/10.3350/..

7

The impact of HCV cure on glycemic indices in patients usin..:

Huang, Chung-Feng ; Kuo, Hsing-Tao ; Chang, Te-Sheng...
Journal of Hepatology. 78 (2023) - p. S1180-S1182 , 2023

Link: https://doi.org/10.1016/..

8

Hepatitis C Virus Reinfection in People With HIV in Taiwan ..:

Liu, Chen-Hua ; Sun, Hsin-Yun ; Peng, Cheng-Yuan...
Open Forum Infectious Diseases. 9 (2022) 8 - p. , 2022

Link: https://doi.org/10.1093/..

9

Metabolic-Associated Fatty Liver Disease, Hepatitis B Surfa..:

Yu, Ming-Whei ; Lin, Chih-Lin ; Liu, Chun-Jen...
Cancers. 14 (2022) 23 - p. 6012 , 2022

Link: https://doi.org/10.3390/..

10

Effectiveness and safety of 8-week glecaprevir/pibrentasvir..:

Hung, Chao-Hung ; Chang, Te-Sheng ; Huang, Chung-Feng...
Journal of Hepatology. 77 (2022) - p. S595-S596 , 2022

Link: https://doi.org/10.1016/..

11

Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term..:

Hsueh, Rei-Chi ; Wu, Wan-Jung ; Lin, Chih-Lin...
Journal of Hepatocellular Carcinoma. 9 (2022) - p. 301-313 , 2022

Link: https://doi.org/10.2147/..

12

Hepatic steatosis and development of type 2 diabetes: Impac..:

Yu, Ming-Whei ; Lin, Chih-Lin ; Liu, Chun-Jen...
Journal of the Formosan Medical Association. 121 (2022) 8 - p. 1478-1487 , 2022

Link: https://doi.org/10.1016/..

13

Management consensus guideline for hepatocellular carcinoma..:

Shao, Yu-Yun ; Wang, Shen-Yung ; Lin, Shi-Ming...
Journal of the Formosan Medical Association. 120 (2021) 4 - p. 1051-1060 , 2021

Link: https://doi.org/10.1016/..

14

Nationwide registry of glecaprevir plus pibrentasvir in the..:

Huang, Chung-Feng ; Kuo, Hsing-Tao ; Chang, Te-Sheng...
Scientific Reports. 11 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

15

THU-241-Influence of HBV genotype on the risk of hepatocell..:

Wu, Wan-Jung ; Kuo, Yi-Chun ; Kao, Wei-Yi...
Journal of Hepatology. 70 (2019) 1 - p. e271 , 2019

Link: https://doi.org/10.1016/..